Skip to main content
. Author manuscript; available in PMC: 2014 Aug 11.
Published in final edited form as: Obesity (Silver Spring). 2011 Aug 4;20(1):40–47. doi: 10.1038/oby.2011.259

Figure 4.

Figure 4

Sulindac and atorvastatin do not enhance zinc finger protein 36 (Zfp36) expression in 3T3-L1 adipocytes. Western blot analysis of Zfp36 expression in 3T3-L1 adipocytes grown in serum-free medium with the following 6 h treatments: vehicle control, dexamethasone (Dex, 1 μmol/l), forskolin (10 μmol/l), the nonsteroidal anti-inflammatory drug (NSAID) sulindac (100 μmol/l), and the lipid-lowering statin drug atorvastatin (5 μmol/l). Quantitative image analysis indicating Zfp36 expression relative to control cells, normalized to actin, is shown. Data are representative of three independent experiments.